Reducing the Genotoxic Potential of Retroviral Vectors
- 1 January 2008
- book chapter
- research article
- Published by Springer Science and Business Media LLC
- Vol. 434, 183-203
- https://doi.org/10.1007/978-1-60327-248-3_12
Abstract
The recent development of leukemia in gene therapy patients with X-linked severe combined immunodeficiency disease because of retroviral vector insertional mutagenesis has prompted reassessment of the genotoxic potential of integrating vector systems. In this chapter, various strategies are described to reduce the associated risks of retroviral genomic integration. These include deletion of strong transcriptional enhancer-promoter elements in the retroviral long terminal repeats, flanking the retroviral transcriptional unit with enhancer blocking sequences and designing vectors with improved RNA \(3^{\prime}\) end processing. Protocols are provided to evaluate the relative biosafety of the modified vectors based on their ability to immortalize hematopoietic progenitor cells and propensity to trigger clonal hematopoiesis or leukemogenesis following hematopoietic stem cell transplantation.
Keywords
This publication has 95 references indexed in Scilit:
- Hematopoietic Stem CellsMethods in Enzymology, 2006
- Stable Gammaretroviral Vector Expression during Embryonic Stem Cell-Derived In Vitro Hematopoietic DevelopmentMolecular Therapy, 2006
- Silencing and Variegation of Gammaretrovirus and Lentivirus VectorsHuman Gene Therapy, 2005
- Gene Therapy Insertional Mutagenesis InsightsScience, 2004
- RTCGD: retroviral tagged cancer gene databaseNucleic Acids Research, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Lentiviral Vectors for Enhanced Gene Expression in Human Hematopoietic CellsMolecular Therapy, 2000
- A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in DrosophilaCell, 1993
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.The Journal of Experimental Medicine, 1992
- Developmental potential and dynamic behavior of hematopoietic stem cellsCell, 1986